Programmatic Update on the use of ARVs to treat pregnant women and prevent mother-to-child transmission of HIV (PMTCT)
Submitted by SHARE Administrator on 11 April 2012
Available on: http://www.who.int/hiv/PMTCT_update.pdf
WHO updates HIV treatment guidance for pregnant women and preventing HIV infection in babies
With little fanfare, the World Health Organization (WHO) recently published a “Programmatic Update” on the use of antiretrovirals (ARVs) to treat pregnant women and prevent mother-to-child transmission of HIV (PMTCT) that identifies Option B and Option B plus as preferable to Option A. Both Option B and Option B+ call for the administration of triple combination antiretroviral therapy (ART) to all pregnant HIV-infected women. Under Option B, antiretroviral therapy would be stopped after the breast feeding period for women with CD4 counts above 350 while Option B + would continue ART in these women for life.
Related countries: Angola, Botswana, Burundi, Congo (Brazzaville), Democratic Republic of the Congo, Equatorial Guinea, Gabon, Kenya, Lesotho, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Rwanda, Seychelles, South Africa, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe
Related themes: HIV prevention